XML 53 R42.htm IDEA: XBRL DOCUMENT v3.4.0.3
INTANGIBLE ASSETS (Details) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, net $ 2,602,078   $ 2,720,541
Amortization expense 198,636 $ 117,161  
Patents [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 9,625,938   9,625,938
Less: accumulated amortization (7,023,860)   (6,905,397)
Intangible assets, net 2,602,078   2,720,541
Amortization expense 118,463 $ 117,161  
Future aggregate amortization expense for intangible assets [Abstract]      
2016 (Nine months) 357,987    
2017 475,148    
2018 475,148    
2019 475,148    
2020 476,450    
2021 & Beyond 342,197    
Total 2,602,078    
Patents [Member] | Amlexanox (Aphthasol) [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 2,090,000   2,090,000
Patents [Member] | Amlexanox (OraDiscA) [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 6,873,080   6,873,080
Patents [Member] | OraDisc [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 73,000   73,000
Patents [Member] | Hydrogel Nanoparticle Aggregate [Member]      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 589,858   $ 589,858